Introduction
Heart failure (HF) is the leading cause of hospitalization in older adults.
1 Hospitalizations burden patients, are associated with a reduced quality of life, and independently predict a higher risk of death. 2 Hospitalizations also burden the healthcare system, contributing to 70-80% of the cost of HF care in developed countries. 3, 4 The period after discharge from hospital represents a time of heightened vulnerability when patients are at risk of clinical deterioration. The daily risk of readmission and death in the month following hospitalization for HF is 0.7% and 0.2%, respectively. 5 As many as 40% of early readmissions may be related to suboptimal transitional care, defined as actions that promote the coordination and continuity of care as patients transfer between healthcare settings or providers. 6, 7 There is no consensus on how long the transitional care period lasts and no standard classification scheme for transitional care services, but interventions generally aim to improve outcomes through supportive, integrated care or closer monitoring. 8 Institutional funding for HF care is linked to outcomes after hospital discharge in some jurisdictions, 9 and previous systematic reviews have demonstrated that discharge planning services can improve clinical outcomes compared with routine care.
10 -16 However, the comparative effectiveness of these services is unclear, and the common elements of effective transitional care services have not been assessed. The European Society of Cardiology guidelines for HF make no recommendations regarding specific transitional care services, other than self-care education of patients and early physician follow-up. 17 In the present study, we systematically review randomized controlled trials (RCTs) that evaluated the efficacy of transitional care services following hospitalization for HF. We conduct a network meta-analysis to assess the comparative effectiveness of these services in reducing all-cause mortality and readmissions. Unlike conventional pairwise meta-analysis, network meta-analysis can compare and rank the effectiveness of treatments relative to one another even if they are not directly compared with each other in clinical trials. 18 Furthermore, because network meta-analyses can include evidence from both direct and indirect comparisons, statistical power may be greater than in simple pairwise meta-analyses that include only direct evidence. 19 This is the first published network meta-analysis that provides a comparative effectiveness of transitional care services. We include services that have not been analysed in previous reviews, evaluate healthcare system costs of services when available, discuss common strategies of effective interventions, and propose a transitional care model that could reduce readmissions and mortality in patients hospitalized for HF.
Methods
This study adheres to the Cochrane Collaboration methodology and PRISMA statement, and International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Task Force on Indirect Treatment Comparisons Good Research Practices. 20, 21 We registered this study with PROSPERO (Registration# CRD42015019031). 22 . 
Data sources and search strategy
We searched PubMed, Embase, Cochrane Review, and CINAHL for articles published between 1 January 2000 and 1 January 2015. We used a combination of MeSH and text terms that encapsulated HF, hospital discharge, multidisciplinary or comprehensive care, and types of transitional care interventions (see the Supplementary material online, Appendix S1).
Study selection
We included RCTs with all of the following features: patient population (patients hospitalized with primary diagnosis of HF and enrolled in the trial either before or immediately after discharge); intervention (a health service intervention that aimed to prepare patients for the transition from hospital to home: the intervention could involve educating, monitoring, clinically following, or supporting the patient in the post-discharge phase, and could be offered in the hospital, the home, or in a clinic); comparator (any other transitional care service or usual care group); primary outcomes (all-cause readmission or mortality after a minimum follow-up of 30 days); studies (RCTs).
We independently reviewed titles, abstracts, and articles for inclusion, and resolved uncertainties through consensus. We excluded studies that did not meet inclusion criteria or: enrolled patients with multiple diagnoses without stratification of results by diagnosis; enrolled healthcare providers as the unit of intervention; tested alternative hospitalization models; described the study methods without reporting the results; or did not publish English translations.
We extracted articles in duplicate and resolved discrepancies by consensus.
Assessment for study quality and risk of bias
For internal validity we assessed study quality with four quality indicators: appropriateness of randomization; blinding of assessor; appropriateness of blinding; and description of losses to follow-up or withdrawals. As patients could not be blinded to the intervention, we only assessed appropriateness of blinding assessors (single-blinding). We assessed for publication bias using Begg's Funnel Plot.
Classification of intervention types
Upon review of the interventions and discussion, we classified services into the following categories:
• Education alone: HF education with a focus on self-care, with no additional planned medical support or follow-up; • Pharmacist interventions: visit by a pharmacist for education, medication reconciliation and optimization; We classified interventions in duplicate and resolved discrepancies by consensus.
Data extraction
We extracted information about study characteristics, methodological quality, patient characteristics, intervention details, and outcomes from each RCT in duplicate, and resolved conflict via consensus.
Clinical outcomes
We measured the clinical outcomes of all-cause mortality and all-cause readmission rate. The number of patients randomized was used as the denominator for mortality, as follow-up for mortality was complete. When time to readmission was not provided, the rate of all-cause readmissions was estimated as the number of readmissions divided by person-time during the follow-up period (estimated by the number of patients followed up multiplied by the follow-up period in months).
Cost outcomes
When data was available, we compared the total cost of care for the intervention group to the usual care group. This included cost of transitional care services and materials in hospital and after discharge, cost of outpatient care, and cost of any readmissions that occurred during the follow up period.
Data analysis
We performed a frequentist network meta-analysis and applied random effects approach to pool data for all transitional care interventions. Consistency of the network was assessed using the loop-specific approach and a net heatplot. 23 We also explored consistency by performing a pairwise meta-analysis and comparing results with those of network meta-analysis. Heterogeneity was quantified using the I 2 index. 24 For the purposes of the analysis, we assumed that the 'usual care' groups across studies had similar effects on outcomes.
For mortality and readmission, we used relative risks and rate ratios, respectively, with 95% confidence intervals (CI). The P-score approach was used to rank effectiveness of interventions, with higher P-scores indicating greater effectiveness. 25 We generated 95% CI around the P-scores using repeated sampling with replacement. 25 Currencies were standardized across countries to reflect purchase power, before pooling the data. Costs were converted to the US dollar (USD) using historical exchange rates on the date that each study was accepted for publication. 26 We adjusted the average per patient cost in USD for inflation using the 2016 US consumer price index 27 and then pooled an estimate of the mean cost difference (control -treatment) with 95% CI from a random intercept model, using sample size of each study as weight.
For traditional meta-analysis we used Stata v12 and for network meta-analysis we used netmeta (version 0.8.0, released 26 June 2015) package in R. 28 
Sensitivity analysis
To determine whether interventions had effects that varied with duration of follow-up, we repeated a network meta-analysis using a random effects model in the pool of studies reporting early (1-6 month) outcomes, and the pool reporting late (>6 month) outcomes. We included all RCTs that were well-connected within the network in this analysis. 23 
Results

Study selection
Our systematic search strategy yielded 1505 citations from PubMed, Embase, CINAHL, and from Cochrane. We excluded 1314 on the basis of redundancy or title/abstract review. We assessed the 191 remaining articles in full text and identified 53 RCTs for inclusion (Figure 1) . The RCTs represented 12 356 randomized patients from 17 countries across Europe and North America.
Interventions tested in the RCTs included education alone (4 RCTs), pharmacist interventions (4 RCTs), telemonitoring (9 RCTs), telephone support (9 RCTs), nurse home visits (6 RCTs), NCM (11 RCTs), and DMCs (11 RCTs). Four of the 53 RCTs compared more than one intervention to usual care, and three compared two interventions without a 'usual care' group.
Baseline characteristics
The mean age of patients in the RCTs ranged from 57 to 85 years. Of the 12 356 patients, 58% were men. Patients in the control and intervention arms of each study were generally well balanced in the characteristics described; however, not all studies described a comprehensive list of baseline characteristics. For example, 19 of the 53 studies did not specify the mean or median left ventricular ejection fraction (LVEF) of patients in each arm. A total of 35 of the 53 studies enrolled patients with a mean LVEF of 40% or less. Baseline use of HF medications, specifically angiotensin-converting enzyme inhibitors and beta-blockers, was reported in 39 studies. Many studies did not clearly describe transitional care processes in the control group. The trials did not consistently report the duration of the intervention, but did report the follow-up period for outcomes. The methodological quality of studies is presented in the Supplementary material online, Table S1 . There was no evidence for publication bias.
Transitional care interventions
The interventions are summarized in Table 1 .
Education alone
Four RCTs assessed the efficacy of education provided by a nurse before discharge, 29 -32 with emphasis on symptom recognition and self-care. Three studies offered a follow-up reinforcement session:
29 -31 two supplemented the curriculum with a take-home video for patients 30, 31 and one used cognitive training and teach-back. 30 
Pharmacist interventions
Pharmacist interventions (n = 4 RCTs) 33 -36 included medication reconciliation, patient education, and medication optimization. In addition, three RCTs provided education on smoking cessation, diet, and disease self-monitoring. 34 -36 The interventions included three to nine home visits by pharmacists.
Telemonitoring
Nine RCTs assessed telemonitoring of vital signs and weight. 37 -45 Two studies required patients to initiate a telephone call and manually record physiological variables with telephone keypads. 37, 38 Three studies used videoconferencing. 39 -41 Three studies had the nurse notify a physician about decompensating patients, 39, 41, 42 and two advised patients with abnormal values to follow-up with their physician. 44, 45 The other studies either did not specify a response or did not detail the nature of the nurse follow-up phone call. 37, 38, 40, 43 
Telephone support
Telephone support (n = 9 RCTs) included structured questions during scheduled telephone encounters. 39, 41, 44, 46 -51 A nurse typically delivered the intervention, although one study used volunteers. 44 The number of telephone calls over the intervention period ranged from 4 to 14. Nurses providing telephone support contacted physicians regarding decompensating patients in three RCTs, 39, 41, 47 and asked patients to follow-up with their physician in another 3 RCTs. 44, 46, 50 Three RCTs did not outline the action in response to deterioration. 48, 49, 51 In addition to telephone support, one study included an initial home visit, 50 and another included follow-up with an internist as a co-intervention.
51
Nurse home visits
Six RCTs offered home visits by HF nurses to provide self-care education and clinical evaluations. 52 -57 In three RCTs, nurses offered one to four visits during the study period. 52 
Disease management clinics
The DMCs (n = 10 RCTs) 68 -78 generally included HF nurses, cardiologists, geriatricians, psychologists, dieticians and/or physiotherapists in an outpatient clinic.
The Supplementary material online, Figure S1 illustrates the direct and indirect comparisons made for this network meta-analysis, with the width of the bar proportional to the number of RCTs in each comparison. 
Effect on mortality
12-18
APN, advanced practice nurse; BNP, B-type natriuretic peptide; BP, blood pressure; HR, heart rate; CHF, congestive heart failure; DMP, disease management programme; ECG, electrocardiogram; GP, general practitioner; HF, heart failure; RN, registered nurse; PCP, primary care physician; DMC, disease management clinic; N/A, not available.
Sensitivity analysis
Among the 21 RCTs reporting short-term follow-up (≤6 months), only DMCs (RR 0.55, 95% CI 0.32-0.97) significantly reduced mortality compared with usual care. Among the 25 RCTs that followed patients for >6 months, nurse home visits (RR 0.81, 95% CI 0.63-1.03), NCM (RR 0.86, 95% CI 0.70-1.06), and DMCs (RR 0.85, 95% CI 0.70-1.03) reduced mortality relative to usual care. Nurse home visits (ranking P-score 0.8365, 95% CI 0.4521-0.9994) were the most effective at decreasing all-cause readmissions, followed by NCM (ranking P-score 0.6168, 95% CI 0.2856-0.9244), and DMCs (ranking P-score 0.5691, 95% CI 0.3239-0.8110), but there were no statistically significant differences in their ranks ( Table 3 , Figure 3 ).
Effect on readmissions
Sensitivity analysis
Among the nine RCTs that followed patients for ≤6 months, nurse home visits (IRR 0.28, 95% CI 0.14-0.54) and DMCs (IRR 0.68, 95% CI 0.44-1.05) reduced the readmission rate ratio compared with usual care. Among the 19 RCTs that followed . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Results of the network meta-analysis are depicted in the forest plot. CI, confidence interval; IRR, incident rate ratio. 
Consistency between network and pairwise meta-analyses
We found no evidence of inconsistency between the network and pairwise comparisons for the outcomes of mortality and readmissions, as summarized in Tables 2 and 3 .
Effect on costs
Compared with usual care, transitional care services reduced overall healthcare system costs (i.e. cost of index hospitalization, intervention, outpatient follow-up, and readmissions) ( Table 4) . Notably, only one of the 18 studies did not include readmission costs in its analysis. Net savings per patient compared with usual care were: education alone, USD 3613 (n = 1); pharmacist interventions, USD 881 (n = 1); telemonitoring, USD 3136 (95% CI 1559-4713) (n = 4); telephone support, USD 12570 (95% CI 10 121-15 019) (n = 3); nurse home visits, USD 3810 (95% CI 3682-3937) (n = 3); NCM, USD 3435 (95% CI 3224-3645) (n = 5); and DMCs, USD 245 (95% CI −70 to 559) (n = 2).
Discussion
This is the first network meta-analysis to assess the comparative effectiveness of transitional care services in decreasing mortality and readmissions after hospitalization for HF. We found that nurse home visits were the most effective strategy to decrease all-cause mortality, followed by DMCs; however, there was no significant difference in their comparative effectiveness on the outcome of mortality. While nurse home visits were the most effective service to decrease all-cause readmissions, followed by NCM and DMCs, there was no significant difference in their comparative effectiveness on this outcome. Nurse visits and DMCs improved clinical outcomes even among RCTs providing short-term follow-up, indicating that benefits are derived early in the post-discharge phase. Telephone support, pharmacist interventions, telemonitoring, and education did not significantly decrease all-cause mortality or all-cause readmissions compared with usual care. Our findings are consistent with two previous reviews that demonstrated that home visiting programmes and clinics improve readmissions and/or mortality relative to usual care.
11,14
Elements of effective interventions included a multidisciplinary approach, recurrent face-to-face contact, education of patients, with an emphasis on self-care, weight monitoring, and pharmacotherapy, and proactive optimization of medications rather than sole reliance on patient triggers. Structured assessments via telephone or telemonitoring may have lacked efficacy as they focused primarily on HF, which accounts for less than half of all readmissions. HF patients. 13 Strategies that include face-to-face assessments may be more effective than remote monitoring at addressing non-cardiovascular conditions that account for approximately 40% of readmissions.
12
We did not include HF mortality or HF readmissions among our outcomes, as these are susceptible to misclassification and/or adjudication bias. 79, 80 We believe that 'all-cause readmissions' is a more useful metric than 'HF readmissions' as it is more relevant to the healthcare system, and costs accrue with a readmission regardless of the diagnosis. Furthermore, all-cause readmissions include admissions resulting from inadequate monitoring of HF treatment.
In an era of escalating healthcare costs, it is worth noting that nurse home visits offered the greatest reduction in deaths and readmissions and the greatest cost savings relative to usual care. This was likely driven by a reduction in readmissions. NCM also significantly decreased healthcare system costs; DMCs reduced costs, but this was not statistically significant. While there are often financial arguments against the implementation of healthcare services that entail upfront costs, the present study demonstrates that there are transitional care services that can improve both clinical and cost outcomes, at least within the context of RCTs. Our results are consistent with a systematic review of HF management programmes, in which interventions that reduced hospital admissions appeared to result in favourable cost outcomes. 81 Our findings have implications on practice and policy. Self-care education alone, provided in the absence of supportive services and recurrent clinical contact in the post-discharge period, has little impact on clinical outcomes. Clinical practice guidelines that emphasize self-care education before hospital discharge could also recommend those transitional care services that improve outcomes following hospitalization, and efforts in implementation could potentially focus on services that improve clinical as well as cost outcomes.
In addition to offering the first comparative effectiveness network meta-analysis of transitional care services, the present study updates previous reviews that evaluated the efficacy of discharge-planning services compared with usual care.
10,11,14 -16 Our review includes the largest number of RCTs (n = 53) comparing the effectiveness of transitional care services following hospitalization for HF; in contrast, a Cochrane review compared health services offered to patients hospitalized for HF with usual care and included 25 RCTs.
11 Other pairwise meta-analyses analysed all types of health service interventions as a single group and included 18 10 and 8 RCTs, 16 respectively. The present study differs from previously published studies in the number of services analysed and the way that interventions were classified.
11,14 While the Cochrane review categorized interventions into one of clinic, case management, or multidisciplinary interventions, 11 we included additional services such as pharmacist interventions, telephone support, and telemonitoring, that are commonly offered to HF patients after hospitalization in many healthcare jurisdictions. We also made distinctions between the types of professionals delivering home visits (e.g. nurses vs. pharmacists), and between single and multifaceted interventions (e.g. home nurse visits vs. telephone support vs. nurse case management, which combined home From a random intercept model using sample size of each study as weight. Currencies are standardized across countries to reflect purchase power, adjusted for the inflation rate and converted to USD using conversion rate on the date that the study was accepted for publication. The mean cost difference (control -intervention) is then pooled to estimate the pooled savings per patient.
visits and telephone support). These distinctions are important for knowledge translation as they can inform the design of 'ideal' transitional care interventions in a given healthcare system. Finally, we include a cost analysis in our review. Limitations should be noted. There is no guidelinerecommended nomenclature for the classification of transitional care services, and our classification scheme varies from others. Considering the complexities of health service interventions, one might even question the merits of classifying services in discrete categories, but this is necessary to synthesize evidence, minimize heterogeneity within categories, and guide efforts directed at implementation. Another limitation is that within each category of services, we could not account for the quality of care provided or fidelity to the intervention. While we excluded statistical heterogeneity before pooling data, variations in quality of the intervention or usual care could have introduced conceptual heterogeneity that cannot be fully accounted for in any meta-analysis. As an example, educational interventions may have varied in goal-setting, use of log books, and other strategies to engage the patients and this may have influenced adherence and/or outcomes. 82 To account for these limitations, we measured the effect of interventions using a conservative method that accounted for within-study as well as between-study variation (random-effects model).
The quality of a network meta-analyses depends on the strength of the network of underlying studies. We recognize that reporting probabilities of which treatment is ranked best can be fragile when the network is sparse, but the network of studies in our primary analysis was relatively robust. 83 The validity of indirect effects rests on the assumption that patients' response rates to usual care are similar across studies and that there is no significant heterogeneity among the studies. These assumptions are similar to those made in standard pairwise meta-analysis. It should be noted that while a conventional pairwise meta-analysis yields only one pooled effect estimate, a network meta-analysis yields more than one pooled effect estimate. Thus, while bias in the effect estimate from any single trial affects a single pooled effect estimate in a conventional meta-analysis, it may affect several pooled effect estimates obtained in a network meta-analysis. 83 However, the indirect effects in the present study were comparable with direct effects, increasing confidence in our findings.
Conclusions
Among transitional care services offered to patients hospitalized for HF, nurse home visits and DMCs decrease all-cause mortality. Along with NCM, they also reduce all-cause readmissions, with no significant difference in comparative effectiveness. These services reduce healthcare system costs to varying degrees.
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